OVERVIEW

Addressing the Burden of Chronic Rhinosinusitis With Nasal Polyps: Strategies for Managing Patients in Rural and Underserved Communities is organized by Rural Medical Education (RME) Collaborative.

Released On: February 28, 2023
Expires On: February 28, 2024

Description:
Chronic rhinosinusitis with nasal polyps (CRSwNP) is an inflammatory disease that affects the nasal mucosa and paranasal sinuses. Patients with CRSwNP experience a high symptom burden including nasal congestion, loss of smell, rhinorrhea, and emotional/sleep symptoms, all of which have been linked to decreased quality of life. Management of CRSwNP can be particularly challenging in rural and underserved communities, where resources and access to specialty care are limited. In this CME/CE activity, expert faculty will review the pathophysiology of CRSwNP, diagnostic criteria and best practices for assessment, and emerging biologic targets and treatment options. Strategies for improving multidisciplinary management of CRSwNP in rural and underserved populations will also be discussed.

Learning Objectives:
Upon completion of this activity, participants should be better able to:
• Describe the pathophysiology and biological mechanisms involved in CRSwNP
• Summarize the efficacy and safety data of new and emerging biologic treatment options for CRSwNP
• Identify appropriate patients with CRSwNP for biologic therapy
• Utilize strategies for improving multidisciplinary care and management of CRSwNP in rural and underserved populations.

Credits

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and RME Collaborative. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour. Designated for 0.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

  • 1 AMA PRA Category 1 Credit™
  • 1 Contact Hours
  • SPECIALITIES

    OtorhinolaryngologyRural Medicine

    RELATED ONLINE COURSES

    Webcast

    Ophthalmology
    2.5 AAPA
    More actions
    US$299

    Webcast

    Otorhinolaryngology
    3 CEU’s
    ...
    More actions